Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized p (Q33365185)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized p |
scientific article |
Statements
1 reference
Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized p (English)
1 reference
Marzena Welnicka-Jaskiewicz
1 reference
Christoph Zielinski
1 reference
Semir Beslija
1 reference
Zrinka Mrsic-Krmpotic
1 reference
Christoph Wiltschke
1 reference
Zsuzsanna Kahan
1 reference
Mislav Grgic
1 reference
Valentina Tzekova
1 reference
Moshe Inbar
1 reference
Jozika Cervek
1 reference
Ivan Chernozemsky
1 reference
Janos Szanto
1 reference
Stanislav Spanik
1 reference
Maria Wagnerova
1 reference
Nicolae Ghilezan
1 reference
Janusz Pawlega
1 reference
Damir Vrbanec
1 reference
Dmitry Khamtsov
1 reference
Victoria Soldatenkova
1 reference
Thomas Brodowicz
1 reference
1 reference
Identifiers
1 reference